Target Name: GPR4
NCBI ID: G2828
Review Report on GPR4 Target / Biomarker Content of Review Report on GPR4 Target / Biomarker
GPR4
Other Name(s): GPR4_HUMAN | G-protein coupled receptor 6C.l | G protein-coupled receptor 4 | G-protein coupled receptor 19 | G-protein coupled receptor 4 | GPR6C.l

Introduction To GPR4 Receptor: Drug Development & Disease Diagnosis

GPR4 (G protein-coupled receptor 4) is a family of important brain receptors that play a variety of physiological roles in the human body. The GPR4 receptor is of high value in drug development and disease diagnosis because it can serve as a drug target or biomarker. This article will introduce in detail the GPR4 receptor and its role in drug research and clinical application.

The GPR4 receptor is a membrane protein that belongs to the G protein-coupled receptor family. Receptors of this family are widely distributed on cell surfaces and are responsible for sensing various signaling molecules, including chemicals, light, sound, etc. As an important brain receptor, GPR4 receptor plays a key role in maintaining the balance of the human body's internal environment and regulating physiological functions.

Application of GPR4 receptor in drug development

As a drug target, GPR4 receptor is of high value in drug research and development. Due to the high selectivity of GPR4 receptors in drug responses, scientists can target specific GPR4 receptors to improve drug efficacy and reduce adverse reactions. At the same time, GPR4 receptor, as a biomarker, can be used for disease diagnosis and prognosis judgment.

In drug research and development, the screening and evaluation of GPR4 receptors as drug targets is very important. Scientists can identify highly selective GPR4 receptors by combining gene expression profiling and drug screening techniques. On this basis, high-throughput screening of these receptors can be performed to find the best drug targets.

Application of GPR4 receptor in disease diagnosis

The application of GPR4 receptors in disease diagnosis mainly includes two aspects: disease diagnosis and prognosis judgment.

First, GPR4 receptors can be used as a disease diagnostic indicator. For example, the GPR4 receptor may be implicated in the treatment of depression. Studies have found that GPR4 receptors are related to the content of neurotransmitters in patients with depression, and that GPR4 receptors are involved in the regulation of neural activity in patients with depression. Therefore, GPR4 receptors can be used as a diagnostic indicator of depression.

Secondly, GPR4 receptor can also be used as a biomarker for disease prognosis. Studies have found that GPR4 receptors are involved in the process of tumor occurrence and progression. Therefore, GPR4 receptor can be used as a prognostic indicator of tumors. By detecting the expression level of GPR4 receptor, the survival period and treatment effect of tumor patients can be predicted, providing an important reference for tumor treatment.

Application of GPR4 receptor in drug research

The application of GPR4 receptors in drug research mainly includes three aspects: drug screening, drug evaluation and drug target confirmation.

First, the GPR4 receptor can be used as a target for drug screening. Due to the high selectivity of GPR4 receptors in drug responses, scientists can conduct drug screening targeting specific GPR4 receptors to screen out drugs with good selectivity.

Secondly, GPR4 receptor can also be used as an indicator for drug evaluation. By detecting the expression levels of GPR4 receptors and drug responses, the efficacy and adverse reactions of drugs can be evaluated, providing an important reference for drug optimization.

Finally, the GPR4 receptor can also be identified as a drug target. By detecting the expression level and physiological activity of GPR4 receptors, the target of drug action can be determined, providing an important theoretical basis for targeted drug intervention.

Application of GPR4 receptor in disease treatment

The application of GPR4 receptors in disease treatment mainly includes two aspects: disease treatment and drug target intervention.

First, the GPR4 receptor can serve as a target for disease treatment. By targeting the GPR4 receptor with pharmaceutical intervention, the risk of the disease can be reduced and symptoms improved. For example, the GPR4 receptor can be used as a target for antidepressant drugs. By enhancing the expression level of the GPR4 receptor, depression can be improved.

Protein Name: G Protein-coupled Receptor 4

Functions: Proton-sensing G-protein coupled receptor couples to multiple intracellular signaling pathways, including GNAS/cAMP, GNAQ/phospholipase C (PLC), and GNA12/GNA13/Rho pathways (PubMed:12955148, PubMed:17462861, PubMed:22110680, PubMed:20211729). Acidosis-induced GPR4 activation increases paracellular gap formation and permeability of vascular endothelial cells through the GNA12/GNA13/Rho GTPase signaling pathway (PubMed:32058960). In the brain may mediate central respiratory sensitivity to CO(2)H(+) (By similarity)

The "GPR4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2 | GRIA3 | GRIA4 | GRID1 | GRID2 | GRID2IP | GRIFIN | GRIK1 | GRIK1-AS1 | GRIK1-AS2 | GRIK2 | GRIK3 | GRIK4 | GRIK5